• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于药物连接性参数和受体蛋白质序列的药物-靶标复合网络的无比对预测。

Alignment-free prediction of a drug-target complex network based on parameters of drug connectivity and protein sequence of receptors.

作者信息

Viña Dolores, Uriarte Eugenio, Orallo Francisco, González-Díaz Humberto

机构信息

Department of Organic Chemistry, University of Santiago de Compostela, 15782, Spain.

出版信息

Mol Pharm. 2009 May-Jun;6(3):825-35. doi: 10.1021/mp800102c.

DOI:10.1021/mp800102c
PMID:19281186
Abstract

There are many drugs described with very different affinity to a large number of receptors. In this work, we selected drug-receptor pairs (DRPs) of affinity/nonaffinity drugs to similar/dissimilar receptors and we represented them as a large network, which may be used to identify drugs that can act on a receptor. Computational chemistry prediction of the biological activity based on quantitative structure-activity relationships (QSAR) substantially increases the potentialities of this kind of networks avoiding time- and resource-consuming experiments. Unfortunately, most QSAR models are unspecific or predict activity against only one receptor. To solve this problem, we developed here a multitarget QSAR (mt-QSAR) classification model. Overall model classification accuracy was 72.25% (1390/1924 compounds) in training, 72.28% (459/635) in cross-validation. Outputs of this mt-QSAR model were used as inputs to construct a network. The observed network has 1735 nodes (DRPs), 1754 edges or pairs of DRPs with similar drug-target affinity (sPDRPs), and low coverage density d = 0.12%. The predicted network has 1735 DRPs, 1857 sPDRPs, and also low coverage density d = 0.12%. After an edge-to-edge comparison (chi-square = 9420.3; p < 0.005), we have demonstrated that the predicted network is significantly similar to the one observed and both have a distribution closer to exponential than to normal.

摘要

有许多药物对大量受体具有截然不同的亲和力。在这项工作中,我们选择了对相似/不同受体具有亲和力/无亲和力的药物-受体对(DRP),并将它们表示为一个大型网络,该网络可用于识别能够作用于某一受体的药物。基于定量构效关系(QSAR)的生物活性计算化学预测极大地提高了这类网络的潜力,避免了耗时耗力的实验。不幸的是,大多数QSAR模型不具有特异性,或仅预测针对一种受体的活性。为了解决这个问题,我们在此开发了一种多靶点QSAR(mt-QSAR)分类模型。在训练中,整体模型分类准确率为72.25%(1390/1924种化合物),在交叉验证中为72.28%(459/635)。该mt-QSAR模型的输出用作构建网络的输入。观察到的网络有1735个节点(DRP)、1754条边或具有相似药物-靶点亲和力的DRP对(sPDRP),覆盖密度较低,d = 0.12%。预测的网络有1735个DRP、1857个sPDRP,覆盖密度也较低,d = 0.12%。经过边对边比较(卡方 = 9420.3;p < 0.005),我们证明预测的网络与观察到的网络显著相似,且两者的分布更接近指数分布而非正态分布。

相似文献

1
Alignment-free prediction of a drug-target complex network based on parameters of drug connectivity and protein sequence of receptors.基于药物连接性参数和受体蛋白质序列的药物-靶标复合网络的无比对预测。
Mol Pharm. 2009 May-Jun;6(3):825-35. doi: 10.1021/mp800102c.
2
Multi-target spectral moments for QSAR and Complex Networks study of antibacterial drugs.多靶标光谱矩用于定量构效关系和抗菌药物复杂网络研究。
Eur J Med Chem. 2009 Nov;44(11):4516-21. doi: 10.1016/j.ejmech.2009.06.018. Epub 2009 Jun 24.
3
Unified QSAR and network-based computational chemistry approach to antimicrobials, part 1: multispecies activity models for antifungals.抗菌剂的统一定量构效关系和基于网络的计算化学方法,第1部分:抗真菌剂的多物种活性模型。
J Comput Chem. 2008 Mar;29(4):656-67. doi: 10.1002/jcc.20826.
4
Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.抗菌剂的统一定量构效关系方法。第3部分:用于抗原生动物化合物的输入编码预测、结构反向投影和复杂网络聚类的首个多任务定量构效关系模型。
Bioorg Med Chem. 2008 Jun 1;16(11):5871-80. doi: 10.1016/j.bmc.2008.04.068. Epub 2008 Apr 29.
5
Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.抗菌剂的统一定量构效关系方法。4. 抗病毒药物 - 药物复合网络巨型组件的多靶点定量构效关系建模与比较多距离研究。
Bioorg Med Chem. 2009 Jan 15;17(2):569-75. doi: 10.1016/j.bmc.2008.11.075. Epub 2008 Dec 6.
6
NL MIND-BEST: a web server for ligands and proteins discovery--theoretic-experimental study of proteins of Giardia lamblia and new compounds active against Plasmodium falciparum.NL MIND-BEST:一个用于配体和蛋白质发现的网络服务器——理论-实验研究蓝氏贾第鞭毛虫蛋白和新的抗疟化合物。
J Theor Biol. 2011 May 7;276(1):229-49. doi: 10.1016/j.jtbi.2011.01.010. Epub 2011 Jan 26.
7
Using entropy of drug and protein graphs to predict FDA drug-target network: theoretic-experimental study of MAO inhibitors and hemoglobin peptides from Fasciola hepatica.利用药物和蛋白质网络图的熵预测 FDA 药物-靶标网络:单胺氧化酶抑制剂和来自 Fasciola hepatica 的血红蛋白肽的理论-实验研究。
Eur J Med Chem. 2011 Apr;46(4):1074-94. doi: 10.1016/j.ejmech.2011.01.023. Epub 2011 Jan 21.
8
MIND-BEST: Web server for drugs and target discovery; design, synthesis, and assay of MAO-B inhibitors and theoretical-experimental study of G3PDH protein from Trichomonas gallinae.MIND-BEST:药物和靶点发现的网络服务器;MAO-B 抑制剂的设计、合成和检测,以及从滴虫中提取的 G3PDH 蛋白的理论-实验研究。
J Proteome Res. 2011 Apr 1;10(4):1698-718. doi: 10.1021/pr101009e. Epub 2011 Feb 24.
9
2D MI-DRAGON: a new predictor for protein-ligands interactions and theoretic-experimental studies of US FDA drug-target network, oxoisoaporphine inhibitors for MAO-A and human parasite proteins.2D MI-DRAGON:一种新的蛋白配体相互作用预测因子,以及美国 FDA 药物靶点网络、MAO-A 抑制剂和人体寄生虫蛋白的理论-实验研究。
Eur J Med Chem. 2011 Dec;46(12):5838-51. doi: 10.1016/j.ejmech.2011.09.045. Epub 2011 Oct 1.
10
Unified QSAR & network-based computational chemistry approach to antimicrobials. II. Multiple distance and triadic census analysis of antiparasitic drugs complex networks.基于统一 QSAR 和网络的计算化学方法研究抗菌药物。II. 抗寄生虫药物复杂网络的多种距离和三元组计数分析。
J Comput Chem. 2010 Jan 15;31(1):164-73. doi: 10.1002/jcc.21292.

引用本文的文献

1
MEGDTA: multi-modal drug-target affinity prediction based on protein three-dimensional structure and ensemble graph neural network.MEGDTA:基于蛋白质三维结构和集成图神经网络的多模态药物-靶点亲和力预测
BMC Genomics. 2025 Aug 11;26(1):738. doi: 10.1186/s12864-025-11943-w.
2
Artificial intelligence and machine-learning approaches in structure and ligand-based discovery of drugs affecting central nervous system.基于结构和配体的影响中枢神经系统药物发现中的人工智能和机器学习方法
Mol Divers. 2023 Apr;27(2):959-985. doi: 10.1007/s11030-022-10489-3. Epub 2022 Jul 11.
3
Artificial intelligence and machine learning-aided drug discovery in central nervous system diseases: State-of-the-arts and future directions.
人工智能和机器学习辅助中枢神经系统疾病药物发现:现状与未来方向。
Med Res Rev. 2021 May;41(3):1427-1473. doi: 10.1002/med.21764. Epub 2020 Dec 9.
4
The urgent need for pan-antiviral agents: from multitarget discovery to multiscale design.对抗病毒药物的迫切需求:从多靶点发现到多尺度设计
Future Med Chem. 2021 Jan;13(1):5-8. doi: 10.4155/fmc-2020-0134. Epub 2020 Nov 23.
5
Targeting HIV/HCV Coinfection Using a Machine Learning-Based Multiple Quantitative Structure-Activity Relationships (Multiple QSAR) Method.基于机器学习的多重定量构效关系(多重 QSAR)方法靶向 HIV/HCV 共感染。
Int J Mol Sci. 2019 Jul 22;20(14):3572. doi: 10.3390/ijms20143572.
6
Computational Prediction and Analysis of Associations between Small Molecules and Binding-Associated S-Nitrosylation Sites.计算预测和分析小分子与结合相关 S-亚硝化位点的关联。
Molecules. 2018 Apr 19;23(4):954. doi: 10.3390/molecules23040954.
7
SimBoost: a read-across approach for predicting drug-target binding affinities using gradient boosting machines.SimBoost:一种使用梯度提升机器预测药物-靶点结合亲和力的类推方法。
J Cheminform. 2017 Apr 18;9(1):24. doi: 10.1186/s13321-017-0209-z.
8
Towards structural systems pharmacology to study complex diseases and personalized medicine.迈向用于研究复杂疾病和个性化医疗的结构系统药理学。
PLoS Comput Biol. 2014 May 15;10(5):e1003554. doi: 10.1371/journal.pcbi.1003554. eCollection 2014 May.
9
Anti-infectious drug repurposing using an integrated chemical genomics and structural systems biology approach.使用综合化学基因组学和结构系统生物学方法进行抗感染药物的重新利用。
Pac Symp Biocomput. 2014:136-47.
10
Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review.分子网络的结构与动态:药物发现的新范例:全面综述。
Pharmacol Ther. 2013 Jun;138(3):333-408. doi: 10.1016/j.pharmthera.2013.01.016. Epub 2013 Feb 4.